Wacker Chemie AG (LON:0NR4)
London · Delayed Price · Currency is GBP · Price in EUR 67.80
+0.85 (1.27%)
At close: Oct 23, 2025
Wacker Chemie AG Revenue
Wacker Chemie AG had revenue of 1.41B EUR in the quarter ending June 30, 2025, a decrease of -3.75%. This brings the company's revenue in the last twelve months to 5.66B, down -3.53% year-over-year. In the year 2024, Wacker Chemie AG had annual revenue of 5.72B, down -10.63%.
Revenue (ttm)
5.66B EUR
Revenue Growth
-3.53%
P/S Ratio
0.62
Revenue / Employee
339.94K EUR
Employees
16,637
Market Cap
3.01B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.72B | -680.40M | -10.63% |
| Dec 31, 2023 | 6.40B | -1.81B | -22.01% |
| Dec 31, 2022 | 8.21B | 2.00B | 32.25% |
| Dec 31, 2021 | 6.21B | 1.52B | 32.29% |
| Dec 31, 2020 | 4.69B | -235.40M | -4.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |